[Angiogenesis and metastasis in colorectal cancer].
Yamada
Kyoji
K
Division of Gastrointestinal Surgery, St. Marianna University School of Medicine.
Yamamura
Takuya
T
Yamaguchi
Susumu
S
D042683:Angiopoietin-1 / Q000502:physiology; D042702:Angiopoietin-2 / Q000502:physiology; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000068258:Bevacizumab; D015179:Colorectal Neoplasms / Q000098:blood supply* / Q000188:drug therapy / Q000473:pathology*; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D000077156:Gefitinib; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D009362:Neoplasm Metastasis / Q000235:genetics; D009389:Neovascularization, Pathologic / Q000235:genetics* / Q000503:physiopathology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
C467630:ANGPT1 protein, human; D042683:Angiopoietin-1; D042702:Angiopoietin-2; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; D011799:Quinazolines; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; C100342:marimastat; D011505:Protein-Tyrosine Kinases; D008666:Metalloendopeptidases; D000077156:Gefitinib